US Patent Issued to Roche Innovation Center Copenhagen on July 1 for "Process for preparing rhenium chelated MAG3 oligonucleotides" (Danish, German Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,625, issued on July 1, was assigned to Roche Innovation Center Copenhagen A/S (Horsholm, Denmark).

"Process for preparing rhenium chelated MAG3 oligonucleotides" was invented by Dennis Jul Hansen (Farum, Denmark), Erik Daa Funder (Hillerod, Denmark) and Joerg Hoernschemeyer (Lorrach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel process for preparing a compound of formula (III) and rhenium chelated MAG3 oligonucleotides."

The patent was filed on April 28, 2020, under Application No. 17/605,058.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacg...